No obvious barriers for GP involvement in potential Moderna rollout Existing infrastructure should allow general practices to take part in the administration of up to 25 million doses of the mRNA COVID vaccine once it is approved for use in Australia.
‘Nervous’ wait for aerosol guidelines following another HQ leak Consensus guidelines on face mask and eye protection against COVID are currently with ICEG for review.
Evidence suggests AstraZeneca and Pfizer are equally effective Experts say the research is reassuring, and indicates that both COVID vaccines offer a pathway to Australia reaching a high level of immunity.
National vaccine program key driver in reduced COVID cases: Study Real-world data has added further weight to the potential public health benefits of mass-vaccination against the coronavirus.
No evidence that recent blood clot deaths were linked to COVID vaccine The TGA has confirmed there is ‘no likely association’ between the deaths of two NSW men and the AstraZeneca vaccine.
Numbers confirm GPs are the ‘backbone’ of COVID vaccine rollout Australia’s GPs have now administered more than 1.05 million vaccine doses – more than half the rollout’s total of 2.03 million.
Are blood clots a concern with mRNA vaccines? An investigation into Australia’s first case of blood clotting after the Pfizer vaccine has yet to confirm a link.
Blood clot case under investigation following Pfizer vaccine The news comes as Australia moves to establish local mRNA manufacturing capacity and experts call for current Pfizer supplies to be redirected to younger cohorts.
Blood clots up to 10 times more common with COVID than vaccines: Study Research has identified the various risks of people experiencing cerebral venous thrombosis, which has been linked to the AstraZeneca vaccine.
‘Seeds of fear and mayhem’: Concerns media hindering vaccine rollout Journalists have a responsibility to not undermine the science and contribute to issues of vaccine hesitancy, according to the RACGP President.